Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 30, 2026 | $6.29 | +10.2% | $71.40B | +6.7% | $7.60 |
| Q1 FY26ended Mar 31, 2026 | May 1, 2026 | $6.26 | +29.1% | $68.29B | +4.6% | $7.57 |
| Q4 FY25ended Dec 31, 2025 | — | $4.65 | −8.3% | $72.13B | +10.3% | — |
| Q3 FY25ended Sep 30, 2025 | — | $6.98 | +165.4% | $69.52B | +9.3% | — |
| Q2 FY25ended Jun 30, 2025 | — | $5.71 | +4.8% | $66.94B | +11.2% | — |
| Q1 FY25ended Mar 31, 2025 | — | $4.85 | — | $65.26B | +14.6% | — |
| Q4 FY24ended Dec 31, 2024 | — | $5.07 | +45.3% | $65.37B | +28.6% | — |
| Q3 FY24ended Sep 30, 2024 | — | $2.63 | −44.5% | $63.61B | +30.5% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe The Cigna shares, not any token. As of Jul 30, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $5.45 | — | $60.20B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | −$0.97 | — | $56.97B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $3.49 | — | $50.82B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $4.74 | — | $48.73B | — | — |